Back to search

Article

Effects of butyrylated high amylose maize starch (HAMSB) as an adjuvant for oral immunotherapy

2025-09-14

Abstract excerpt

<h4>Background</h4> Oral immunotherapy (OIT) is an important treatment option for food allergy but achieving sustained unresponsiveness (SU) via OIT is challenging. Improving SU for OIT with adjuvants is of great interest but little progress has been made so far. Gut microbiota-derived metabolites like short-chain fatty acids (SCFAs) protect against food allergy in mouse models via promoting regulatory T cells (T...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
50774a23-9387-5296-ae3a-8e6f490deaf9
DOI
10.1101/2025.09.11.25335560
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effects of butyrylated high amylose maize starch (HAMSB) as an adjuvant for oral immunotherapyDOI 10.1101/2025.09.11.25335560
Select a neighboring publication to make it the new centre.